Al Khayyat Investments expands foray in mobile commerce with BinSina Pharmacy Arabic app

  • Al Khayyat Investments appoints a new leadership team for its flagship brand, BinSina Pharmacy, to accelerate its MENA expansion plans

Dubai, UAE: Al Khayyat Investments (AKI), one of the UAE’s prominent family-owned conglomerates, is setting the stage for the accelerated growth of its pharmacy business in the MENA region, investing in both digital infrastructure and human capital.

AKI’s popular BinSina pharmacy brand has unveiled an updated mobile app that offers Arabic-speaking customers a flawless browsing, ordering and delivery tracking experience anywhere. The app already offers 6,000 individual items to consumers and will scale to 10,000 in the next six months. The pharmacy app will be accessible in English and Arabic in the UAE, with plans to roll out the app to additional markets soon, following BinSina’s expansion into Oman.

Also Read :  Apple iPhone maker Foxconn says it wants to make cars for Tesla

The move comes as analytics firm AppsFlyer notes that UAE businesses are doubling down on mobile apps in a bid to increase customer engagement and spending, with mobile app downloads in the UAE growing by 23% annually in the first half of 2022.

Seeing potential in both e-commerce and brick and mortar retail, AKI has also brought together a new leadership team to deliver on its expansion ambitions. At the helm is industry veteran Dr. Doaa Marouf, who was promoted to CEO of AKI Pharma and BinSina Pharmacy. Joining Marouf will be Della Pass, who is new to AKI and has joined as Senior GM of BinSina Pharmacy, as well as overseeing the Holland & Barrett brand within AKI.

Also Read :  ICICI Bank UK offers bank accounts in UK for Indian students: How to activate it in 3 steps

Zaid S. Al Khayyat, Managing Director of Al Khayyat Investments (AKI), says: “AKI has long been at the forefront of the pharma sector, working with partners to not only bring the world’s best products to local communities, but to create innovative retail.models.Our latest investments in both people and infrastructure reflect our belief in always moving the market forward.

“BinSina Apdikt has been on an accelerated growth path in recent years, fueled in part by the state-of-the-art digital infrastructure that helps us serve consumers anytime, anywhere,” adds Dr. Doaa Marouf, CEO of AKI Pharma and BinSina Apdikt. “Together with a senior management team with many years of entrepreneurial experience, there is no limit to where we can go.”

AKI currently has a footprint across eight countries in the wider Middle East and Africa region, entering Saudi Arabia and Egypt in 2022.

Also Read :  Active Pharmaceutical Ingredients (API) Global Market

-end-

About Al Khayyat Investments

Founded in 1982 in the UAE, Al Khayyat Investments (AKI) is a family-owned conglomerate considered a pioneer in various industries in the Middle East, providing profitable partnerships through specialized industry expertise. AKI enjoys sustained growth in many sectors including: distribution, retail, healthcare, contracting, fitness & leisure, and automotive. While AKI is recognized as one of the region’s trusted business partners for local and global companies, it is also an innovative architect of full-scale concepts in the retail sector.

AKI has grown exponentially over the past four decades with over 5,500 employees representing more than 54 nationalities.

For media inquiries, please contact:
Weber Shandwick MENAT
[email protected]

Source

Leave a Reply

Your email address will not be published.